News

THE LAWSUIT: A class action securities lawsuit was filed against Organon & Co. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between October ...
Organon and GSK did not immediately respond ... suicidal thoughts should be included as a side effect for finasteride tablets, but said the benefits of finasteride and dutasteride medicines ...
Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in share price following a >90% dividend cut. The company's revenue ...
Shares of NYSE OGN opened at $9.60 on Friday. Organon & Co. has a twelve month low of $9.18 and a twelve month high of $23.10. The company has a 50 day moving average of $13.46 and a 200 day ...
Cuneiform tablets from ancient Mesopotamia cover a range of topics, from exorcising ghosts to uncovering the location of Noah’s Ark. Cuneiform tablet, c. 2nd–1st century B.C.E., Mesopotamia ...
I’ve tested tech for nearly a decade, and it’s always been a bit difficult to find the best Android tablet for most people. Unlike the relatively simple decision of finding the right iPad ...
JERSEY CITY, N.J. - Organon (NYSE: OGN), a global healthcare company specializing in women’s health, has announced the expansion of its Board of Directors with the appointment of Ramona A.
Daily subcutaneous injections of approximately 0.25 mg of either cetrorelix acetate (Cetrotide®, Merck Serono, Germany) or ganirelix acetate (Orgalutran®, Organon ... in addition to oral ...
Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...
Tablets have evolved into powerful tools that can transform how we work, create, and relax. In 2025, top brands like Apple, Samsung, and others offer devices packed with advanced features designed ...